Cargando…
Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
SIMPLE SUMMARY: Our knowledge about the identity of many cancers has increased greatly during the last years and progress in their early identification as well as treatment options led to a net increase in the survival of many cancer patients. Unfortunately, gastric cancer does not belong to these c...
Autores principales: | Badie, Amandine, Gaiddon, Christian, Mellitzer, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659209/ https://www.ncbi.nlm.nih.gov/pubmed/36358890 http://dx.doi.org/10.3390/cancers14215472 |
Ejemplares similares
-
Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair
por: Blanchet, Anais, et al.
Publicado: (2021) -
HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway
por: Spaety, Marie-Elodie, et al.
Publicado: (2019) -
Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer
por: Venkatasamy, Aina, et al.
Publicado: (2021) -
Patho-epigenetics: histone deacetylases as targets of pathogens and therapeutics
por: Schator, Daniel, et al.
Publicado: (2021) -
Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis
por: Jiang, Li-Ping, et al.
Publicado: (2022)